1033 related articles for article (PubMed ID: 19490962)
1. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
[TBL] [Abstract][Full Text] [Related]
3. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
Titball RW; Burtnick MN; Bancroft GJ; Brett P
Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210
[TBL] [Abstract][Full Text] [Related]
4. Human single-chain Fv antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Zou N; Newsome T; Li B; Tsai S; Lo SC
Exp Biol Med (Maywood); 2007 Apr; 232(4):550-6. PubMed ID: 17392491
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
[TBL] [Abstract][Full Text] [Related]
6. Development of Burkholderia mallei and pseudomallei vaccines.
Silva EB; Dow SW
Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
[TBL] [Abstract][Full Text] [Related]
7. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.
Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ
Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938
[TBL] [Abstract][Full Text] [Related]
8. Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
Bondi SK; Goldberg JB
Expert Rev Vaccines; 2008 Nov; 7(9):1357-65. PubMed ID: 18980539
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against
Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
[No Abstract] [Full Text] [Related]
10. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ
FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960
[TBL] [Abstract][Full Text] [Related]
11. Burkholderia vaccines: are we moving forward?
Choh LC; Ong GH; Vellasamy KM; Kalaiselvam K; Kang WT; Al-Maleki AR; Mariappan V; Vadivelu J
Front Cell Infect Microbiol; 2013; 3():5. PubMed ID: 23386999
[TBL] [Abstract][Full Text] [Related]
12. Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice.
Ulrich RL; Amemiya K; Waag DM; Roy CJ; DeShazer D
Vaccine; 2005 Mar; 23(16):1986-92. PubMed ID: 15734072
[TBL] [Abstract][Full Text] [Related]
13. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.
Su YC; Wan KL; Mohamed R; Nathan S
Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831
[TBL] [Abstract][Full Text] [Related]
14. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
[TBL] [Abstract][Full Text] [Related]
15. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
[TBL] [Abstract][Full Text] [Related]
16. Antibodies from patients with melioidosis recognize Burkholderia mallei but not Burkholderia thailandensis antigens in the indirect hemagglutination assay.
Tiyawisutsri R; Peacock SJ; Langa S; Limmathurotsakul D; Cheng AC; Chierakul W; Chaowagul W; Day NP; Wuthiekanun V
J Clin Microbiol; 2005 Sep; 43(9):4872-4. PubMed ID: 16145163
[TBL] [Abstract][Full Text] [Related]
17. Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle.
Breitbach K; Köhler J; Steinmetz I
Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S89-94. PubMed ID: 19121696
[TBL] [Abstract][Full Text] [Related]
18. Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis.
Tiyawisutsri R; Holden MT; Tumapa S; Rengpipat S; Clarke SR; Foster SJ; Nierman WC; Day NP; Peacock SJ
BMC Microbiol; 2007 Mar; 7():19. PubMed ID: 17362501
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.
Barnes KB; Steward J; Thwaite JE; Lever MS; Davies CH; Armstrong SJ; Laws TR; Roughley N; Harding SV; Atkins TP; Simpson AJ; Atkins HS
Int J Antimicrob Agents; 2013 Jun; 41(6):552-7. PubMed ID: 23517714
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice.
Amemiya K; Meyers JL; Trevino SR; Chanh TC; Norris SL; Waag DM
Vaccine; 2006 Feb; 24(9):1413-20. PubMed ID: 16213631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
